The company expired its plan on December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -3.74% | -8.04% | +17.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.05% | 130M | |
+38.36% | 52.73B | |
+36.73% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics, Inc.'s Equity Buyback announced on June 27, 2023, has expired with 1,320,046 shares, representing 1.04% for $1.44 million.